Pelvic exenteration for advanced primary and recurrent adenocarcinoma

R. E. Falk, F. L. Moffat, L. Makowka, G. Konn, M. A. Bulbul, L. E. Rotstein, A. W. Bruce

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


The authors report on 45 patients who have undergone pelvic exenteration for adenocarcinoma since 1979. Three patients underwent exenteration as the initial treatment for their disease but all others had had previous surgery, radiotherapy or chemotherapy. Operating time and blood loss were lower in previously irradiated patients. There were seven inhospital deaths (15.5%). The number of complications and length of postoperative hospital stay have decreased significantly as experience with pelvic exenteration has been acquired. Symptoms have been controlled in a high proportion of patients. Exenterative surgery is an effective method of treatment in selected patients with pelvic adenocarcinoma but should be undertaken only by experienced surgeons who have access to a wide range of supportive facilities for optimal perioperative management.

Original languageEnglish (US)
Pages (from-to)539-541
Number of pages3
JournalCanadian Journal of Surgery
Issue number6
StatePublished - 1985
Externally publishedYes

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Pelvic exenteration for advanced primary and recurrent adenocarcinoma'. Together they form a unique fingerprint.

Cite this